» Articles » PMID: 8976286

Mechanisms by Which Fibrin and Fibronectin Appear in Healing Wounds: Implications for Peyronie's Disease

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 1997 Jan 1
PMID 8976286
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The extracellular matrix that is present at sites of tissue repair in most instances undergoes an orderly transition from a fibrin containing matrix to collagen-rich scar. However, in some conditions, such as Peyronie's disease, fibrin persists. Evidence from a number of experimental systems indicates that extracellular matrix proteins and their receptors serve an important function in regulating cell behaviors. Thus, the presence of the fibrin matrix is likely to have important implications in the course of either normal or pathogenic wound healing as occurs in Peyronie's disease. Potential mechanisms by which the fibrin rich provisional matrix appears in healing wounds are presented.

Materials And Methods: Methodologies, such as in situ hybridization, immunolocalization and labeled tracer techniques, were used in our study.

Results: We found by these approaches that the 2 general mechanisms that contribute to the generation of the wound extracellular matrix are leakage of plasma proteins, such as plasma fibronectin and fibrinogen, and the synthesis of variants of fibronectin by wound cells.

Conclusions: Developing an understanding of the mechanisms that regulate the appearance of these matrix proteins may provide new avenues for therapy in conditions such as Peyronie's disease in which the temporal pattern of the provisional matrix deposition is abnormal.

Citing Articles

Low-intensity extracorporeal shockwave therapy for Peyronie's disease: An Indian experience.

Maiti K, Srivastava S, Pal D Indian J Urol. 2023; 39(3):209-215.

PMID: 37575155 PMC: 10419780. DOI: 10.4103/iju.iju_22_23.


Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie's Disease.

Mitsui Y, Yamabe F, Hori S, Uetani M, Kobayashi H, Nagao K Int J Mol Sci. 2023; 24(12).

PMID: 37373277 PMC: 10299070. DOI: 10.3390/ijms241210133.


The contribution of the immune system to genitourinary fibrosis.

Doersch K, Barnett D, Chase A, Johnston D, Gabrielsen J Exp Biol Med (Maywood). 2022; 247(9):765-778.

PMID: 35531654 PMC: 9134766. DOI: 10.1177/15353702221090872.


Clinical use of hyaluronic acid in andrology: A review.

Zucchi A, Scroppo F, Capogrosso P, Salonia A, Duante J, Bini V Andrology. 2021; 10(1):42-50.

PMID: 34297894 PMC: 9135118. DOI: 10.1111/andr.13083.


New insights into the pathogenesis of Peyronie's disease: A narrative review.

Krakhotkin D, Chernylovskyi V, Mottrie A, Greco F, Bugaev R Chronic Dis Transl Med. 2020; 6(3):165-181.

PMID: 32885153 PMC: 7451633. DOI: 10.1016/j.cdtm.2020.06.001.